First Interstate Bank’s Ionis Pharmaceuticals IONS Stock Holding History

First Interstate Bank’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-419	Closed	-$25K	–	325
2019 Q4	$25K	Hold	419	–	–	0.01%	332
2019 Q3	$25K	Hold	419	–	–	0.01%	387
2019 Q2	$27K	Hold	419	–	–	0.01%	419
2019 Q1	$34K	Buy	+419	New	+$27K	0.01%	393

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Interstate Bank's IONS Position: Q1 2020 in Review

First Interstate Bank sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 419 shares — an estimated $25K sold.

First Interstate Bank first reported a position in IONS in Q1 2019 and held it in 4 quarters. The position peaked at $34K in Q1 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

First Interstate Bank reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
First Interstate Bank sold 419 Ionis Pharmaceuticals shares in Q1 2020, an estimated $25K.
First Interstate Bank first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 4 quarters.
First Interstate Bank's Ionis Pharmaceuticals position peaked at $34K in Q1 2019.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on First Interstate Bank's 13F filing for Q1 2020, filed 11 May 2020.